Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04761744
Status:
UNKNOWN
Last Update Posted:
2021-02-21
First Post:
2021-02-16
Brief Title:
A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers
Sponsor:
Korean Cancer Study Group
Organization:
Korean Cancer Study Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Solid Tumor |
| DDR Gene Mutation |
Keywords:
| Name | View |
|---|---|
| Nivolumab | View |